Investor's Calendar

December 2023

Mon Tue Wed Thu Fri Sat Sun
27
28
29
30
1
2
3
 
 
 
 
 
 
 
4
5
6
7
8
9
10
 
 
 
 
 
 
 
11
12
13
14
15
16
17
 
 
 
 
 
 
 
18
19
20
21
22
23
24
 
 
 
 
 
 
 
25
26
27
28
29
30
31
 
 
 
 
 
 
 

Last News

First nine months 2023 results press release
ROVI reports operating revenue growth of 3% for the first nine months of the first post-pandemic year
5 min
08 Nov, 2023
ROVI takes first place in the Sustainalytics world ESG risk ranking for the second year...
For the second year running, ROVI has obtained the best ranking in the pharmaceutical industry category in...
3 min
04 Aug, 2023
ROVI informs on the evaluation process to obtain marketing authorisation for Risvan®
Risperidone ISM® is a prolonged-release injectable antipsychotic developed and patented by ROVI for the...
1 min
28 Jul, 2023

See more

Financial and Business Information

Information for investors

Marta Campos

Marta Campos

Head of Investor Relations

mcampos@rovi.es

Antonio Marquina

Antonio Marquina

Investor Relations

amarquina@rovi.es

buzón general Rovi

General Email

ir@rovi.es